Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001641172-25-010930·Korsana Biosciences, Inc.
Schedule 13G ownership disclosure
CYCLERION THERAPEUTICS INC
Common Stock, no par value · CUSIP: 23255M204
Event date: 2025-03-31
- Filing-level shares
- 164,777.00
- Percent of class
- 5.1%
- Tyndall Capital Partners, L.P.
Shares: 164,777.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-010930
- Form type
- SCHEDULE 13G/A
- Filer
- Korsana Biosciences, Inc.
- CIK
- CIK 1755237
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership